Loading…
Tuesday, June 20 • 10:30am - 11:45am
#212: Walking the Walk in Patient Focused Medicines Development: From Theory to Practice What Have We Learned?

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Forum
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-17-524-L04-P; CME 1.25; IACET 1.25; RN 1.25

This forum will focus on the practical side of patient engagement ensuring that attendees get a real life view of the topic. Participants/panelists who have a passion for patient engagement and play key roles in their organizations to make patient engagement happen will be invited to participate – again providing a realistic insight into their approaches, initiatives, challenges, and successes. They will also provide a wealth and diversity of experience to drive a dynamic and interactive discussion that will encourage all attendees to participate.

Join Patient Engagement Community for a follow up Round Table discussion at 1:00pm in the Community Corner.

Learning Objectives

Discuss various approaches to patient engagement; Describe some initiatives for patient engagement along with challenges and success stories.

Chair

Marc M. Boutin, JD

Speaker

EMA Perspective
Juan Garcia-Burgos, MD

FDA Perspective
Theresa M. Mullin, PhD

Patient Perspective
Jan Geissler, MBA

Industry Perspective
Anton Hoos, MD, PhD, MBA



Moderators
avatar for Marc Boutin

Marc Boutin

Chief Executive Officer, National Health Council (NHC)
Marc M. Boutin, JD, is the Chief Executive Officer of the National Health Council. He has been a leading voice for greater patient involvement at every stage of the health care continuum. Boutin has been actively involved in patient advocacy organization management, health advocacy... Read More →

Speakers
avatar for Juan Garcia-Burgos

Juan Garcia-Burgos

Head of Public Engagement Department, European Medicines Agency (EMA)
Juan Garcia Burgos is Head of Public Engagement Department and Co-chair of the EMA patients’ & healthcare professionals’ working parties. He is a Medical Doctor specialised in urology. In 2002 he joined the EMA to coordinate the preparation of EU clinical guidelines for drug development... Read More →
avatar for Jan Geissler

Jan Geissler

CEO, Patvocates
Founder and Managing Director of Patvocates. Former Director of the European Patients' Academy (EUPATI). Cancer survivor and co-founder of the CML Advocates Network, the Leukemia Patient Advocates Foundation, LeukaNET, Leukämie-Online and the European Cancer Patient Coalition.
avatar for Anton Hoos

Anton Hoos

Vice President and Medical Director, Europe, Amgen GmbH
Tony Hoos currently serves as the Chief of Medical for Amgen in Europe, which includes all therapeutic areas as well as all medical departments in Europe. Tony has been passionate about patient involvement in the development and life cycle of medicines for many years. He has worked... Read More →
avatar for Theresa Mullin

Theresa Mullin

Associate Director for Strategic Initiatives, OCD, CDER, FDA
Principal advisor on strategy including CDER international cooperation and harmonization, application of decision science, and other initiatives. Leads FDA Patient Focused Drug Development, and heads the FDA delegation to ICH. Previous work includes leading FDA negotiations for 2002... Read More →


Tuesday June 20, 2017 10:30am - 11:45am
N426a McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616